Cancer Biopsy Market Expected to Reach US$22.86 Bn by 2022, Growing at a CAGR of 14.7% Over the Forecast Period 2023-2030
Cancer Biopsy Market Market Overview: The global Cancer Biopsy Market is estimated to be valued at US$22.86 billion in 2022 and is expected to exhibit a CAGR of 14.7% over the forecast period 2023-2030. Cancer biopsy refers to the surgical removal of tissue samples from the body for testing and analysis, aiding in the diagnosis and treatment of cancer. Biopsy samples are collected using various techniques such as aspiration, needle biopsy, incision biopsy, and excision biopsy. Advancements in technology and increasing awareness about early cancer detection are driving the growth of this market. Moreover, the rising prevalence of cancer worldwide and the need for personalized treatment plans are further fueling the demand for cancer biopsy procedures. Market Key Trends: One key trend in the Cancer Biopsy Market is the integration of artificial intelligence (AI) algorithms for improving biopsy accuracy and efficiency. AI algorithms analyze large volumes of patient data, including medi...